Akso Health Group (AHG)
0.8168
-0.03
(-3.68%)
USD |
NASDAQ |
Sep 08, 16:00
0.811
-0.01
(-0.71%)
Pre-Market: 20:00
Akso Health Group Enterprise Value : 706.25M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 706.25M |
| September 04, 2026 | 732.89M |
| September 03, 2026 | 754.93M |
| September 02, 2026 | 734.60M |
| September 01, 2026 | 777.30M |
| August 31, 2026 | 777.30M |
| August 28, 2026 | 740.41M |
| August 27, 2026 | 845.63M |
| August 26, 2026 | 854.17M |
| August 25, 2026 | 849.22M |
| August 24, 2026 | 814.07M |
| August 21, 2026 | 802.67M |
| August 20, 2026 | 879.79M |
| August 19, 2026 | 834.27M |
| August 18, 2026 | 901.14M |
| August 17, 2026 | 1.042B |
| August 14, 2026 | 1.093B |
| August 13, 2026 | 1.119B |
| August 12, 2026 | 1.264B |
| August 11, 2026 | 1.196B |
| August 10, 2026 | 1.162B |
| August 07, 2026 | 1.162B |
| August 06, 2026 | 1.136B |
| August 05, 2026 | 1.256B |
| August 04, 2026 | 1.227B |
| Date | Value |
|---|---|
| August 03, 2026 | 1.145B |
| July 31, 2026 | 1.350B |
| July 30, 2026 | 1.367B |
| July 29, 2026 | 1.256B |
| July 28, 2026 | 1.256B |
| July 27, 2026 | 1.256B |
| July 24, 2026 | 1.298B |
| July 23, 2026 | 1.264B |
| July 22, 2026 | 1.238B |
| July 21, 2026 | 1.375B |
| July 20, 2026 | 1.358B |
| July 17, 2026 | 1.298B |
| July 16, 2026 | 1.341B |
| July 15, 2026 | 1.315B |
| July 14, 2026 | 1.307B |
| July 13, 2026 | 1.273B |
| July 10, 2026 | 1.307B |
| July 09, 2026 | 1.281B |
| July 08, 2026 | 1.375B |
| July 07, 2026 | 1.341B |
| July 06, 2026 | 1.311B |
| July 02, 2026 | 1.307B |
| July 01, 2026 | 1.298B |
| June 30, 2026 | 1.281B |
| June 29, 2026 | 1.247B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Interpace Biosciences, Inc. | 36.58M |
| Concord Medical Services Holdings Ltd. | 111.91M |
| Exlites Holdings International, Inc. | 15.42M |
| Xcelerate, Inc. | 6.358M |
| Fresenius SE & Co. KGaA | 41.61B |
Enterprise Value Related Metrics
| Earnings Yield | -2.77% |
| Normalized Earnings Yield | -1.090 |